www.fdanews.com/articles/88232-pharma-blog-watch
Pharma Blog Watch
July 10, 2006
FavId Shows Promise
for relapsed NHL patients (The Pharm Voice)
In her blog, Gloria Gamat
discusses Favrille's recently announced results of a Phase II trial of its non-Hodgkin's
lymphoma (NHL) drug FavId.